Atyr Pharma's Q3 Loss: $0.26 per Share
Markets & Money Today | 2 Min News | The Daily News Now! - A podcast by The Daily News Now! - Domenica
Categorie:
Atyr Pharmas Q3 financials reveal a staggering loss of $25.7 million, or $0.26 per share, falling short of Wall Streets predictions. Despite a modest revenue of $190,000, the companys shares plummeted from $3.25 to $0.77, reflecting market concerns over their performance in the biotherapeutics sector.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.
